Fukuda Denshi Co., Ltd.

Tokyo Stock Exchange 6960.T

Fukuda Denshi Co., Ltd. Operating Cash Flow for the year ending March 31, 2024: USD 158.00 M

Fukuda Denshi Co., Ltd. Operating Cash Flow is USD 158.00 M for the year ending March 31, 2024, a -9.27% change year over year. Operating cash flow is cash generated from the company’s regular business operations.

Fukuda Denshi Co., Ltd. Operating Cash Flow for the year ending March 31, 2023 was USD 174.15 M, a -8.27% change year over year.
Fukuda Denshi Co., Ltd. Operating Cash Flow for the year ending March 31, 2022 was USD 189.86 M, a -3.30% change year over year.
Fukuda Denshi Co., Ltd. Operating Cash Flow for the year ending March 31, 2021 was USD 196.34 M, a 4.35% change year over year.
Fukuda Denshi Co., Ltd. Operating Cash Flow for the year ending March 31, 2020 was USD 188.15 M, a 49.23% change year over year.

Key data

Date	Operating Cash Flow	Net Cash Used For Investing Activities	Net Cash Used Provided By Financing Activities	Dividends Paid

Tokyo Stock Exchange: 6960.T

Fukuda Denshi Co., Ltd.

CEO	Mr. Kotaro Fukuda
IPO Date	Jan. 4, 2000
Location	Japan
Headquarters	2-35-8 Hongo
Employees	3,443
Sector	Healthcare
Industries Medical Instruments Hardware & Electronics Telehealth

Description

Fukuda Denshi Co., Ltd. engages in manufacture and sale of medical instruments in Japan and internationally. It offers resting electrocardiograph products; data management software; stress test products; and patient monitoring systems, including central and bedside monitors, transmitters, and central viewer workstations; and vascular screening systems. The company was founded in 1939 and is based in Tokyo, Japan.

Key trends

Past 5 years